Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor

Carlos J P Alvarez1, María Lodeiro, Marily Theodoropoulou

  • 1Laboratorio de Endocrinología Molecular y Celular, Instituto de Investigaciones Sanitarias, Complejo Hospitalario Universitario de Santiago (CHUS), 15706 Santiago de Compostela, Spain.

Endocrine-Related Cancer
|January 21, 2009
PubMed

Insights

Obestatin activates Akt signaling through a novel pathway involving GPR39, beta-arrestin 1, and EGFR. This process requires specific phosphorylation events mediated by PDK1 and mTORC2, independent of G protein signaling.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Signaling

Background:

  • Obestatin, a gut peptide from the ghrelin gene, binds to the G protein-coupled receptor GPR39.
  • Understanding obestatin's intracellular signaling is crucial for elucidating its physiological roles.

Purpose of the Study:

  • To characterize the transmembrane signaling pathway of obestatin.
  • To identify the intracellular mechanisms responsible for Akt activation by obestatin.

Main Methods:

  • Sequential analysis of obestatin's transmembrane signaling pathway.
  • Investigated Akt activation through phosphorylation site analysis (T308, S473).
  • Examined the roles of G protein subunits, beta-arrestin 1, Src, and EGFR.

Main Results:

  • Akt activation requires T308 phosphorylation by phosphoinositide-dependent kinase 1 (PDK1) and S473 phosphorylation by mTOR kinase complex 2 (mTORC2).
  • Obestatin triggers GPR39/beta-arrestin 1/Src complex formation, leading to epidermal growth factor receptor (EGFR) transactivation.
  • Obestatin administration increased phosphorylation of mTOR and p70S6K1, paralleling Akt activation.

Conclusions:

  • A novel signaling pathway for obestatin-mediated Akt activation is proposed, involving beta-arrestin 1 scaffolding and EGFR transactivation.
  • This pathway is independent of G(i/o)-protein and Gbetagamma dimers.
  • Elucidates key molecular events in obestatin signaling.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.